Support for innovative research to improve cancer control through behavior modification, screening, and understanding etiologic factors, with the aim of advancing population-based cancer studies.
This grant supports planning of cancer prevention and control clinical trials to enhance trial design, feasibility, and reduce costs for effective cancer interventions.
NIH's R21 grant funds high-risk, early-stage research with potential for breakthroughs in biomedical, behavioral, or clinical fields, excluding clinical trials.
Support basic research to uncover biological/genetic causes of cancer health disparities through innovative studies, methodologies, and data analysis.
NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.
Facilitates well-planned cancer prevention and control clinical trials by addressing information gaps to improve trial design and feasibility, saving time and money for NCI.